See also this year's filing and all EDGAR filings for this company.
PDF Report 0001744659_2023_Akero_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001744659, Akero Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 355,173,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 47,000 |
| 3 | remainder_Assets | 1,350,000 |
| 4 | LiabilitiesCurrent | 19,083,000 |
| 5 | LiabilitiesNoncurrent | 1,079,000 |
| 6 | remainder_Liabilities | 9,846,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 739,000 |
| 11 | remainder_Revenues | 3,862,000 |
| 12 | remainder_NetIncome | -115,156,000 |
| 13 | remainder_ComprehensiveNetIncome | 64,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 356,570,000 |
| 1 | Liabilities | 30,008,000 |
| 2 | Expenses | 739,000 |
| 3 | Revenues | 3,862,000 |
| 4 | StockholdersEquity | 326,562,000 |
| 5 | NetIncome | -112,033,000 |
| 6 | ComprehensiveNetIncome | -112,001,000 |
| 7 | BaseVar | 253,199,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.10 |
| 9 | EconomicCapitalRatio | 3.76 |
Edgar->Model Mapping
Feature Distribution
